Colon Cancer Treatment - Phase III C-08 Study Of Avastin In Early-stage Colon Cancer Does Not - Medical News Today
Phase III C-08 Study Of Avastin In Early-stage Colon Cancer Does Not - Medical News Today
Roche announced the results of the first phase III trial evaluating the use of Avastin (bevacizumab) plus chemotherapy (FOLFOX) for the treatment of colon cancer immediately following surgery (adjuvant therapy) compared to chemotherapy alone. The
Hormone therapy lowers colon cancer risk: studies - Reuters
WASHINGTON (Reuters) - Hormone replacement therapy may raise a woman’s risk of breast cancer and heart disease but it lowers her risk of colon cancer, according to two studies released on Wednesday. The studies presented at a meeting of the American
Avastin Falls Short in Test as Colon Cancer Medicine - New York Times
In results from a widely watched clinical trial, the drug Avastin failed to show a significant effect on preventing the recurrence of colon cancer , the drug s maker, Genentech, said early Wednesday. Although Avastin is already a best-selling
Avastin fails to hit colon cancer target - United Press International
SAN FRANCISCO, April 22 (UPI) — The drug Avastin fell short in a clinical trial of its goal to reduce the recurrence of early-stage colon cancer, U.S. drug maker Genentech says. The Phase III study, which looked at the effectiveness of chemotherapy